PATENT CLAIM ANALYSIS

Application Number: 16166220
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["530", "391900"]

Abstract:
Disclosed herein is an immunoconjugate comprising an antibody, a functional motif, and a linker connecting the functional motif to the antibody. According to embodiments of the present disclosure, the antibody may recognize tumor-associated antigens (TAAs), and serves as a targeting module for delivering the functional motif connected therewith to the tumor cells thereby inhibiting tumor growth or detecting the distribution of tumor cells. Also disclosed herein are methods of treating cancers and methods of diagnosing cancers by use of the present immunoconjugate.

Claim (Index 14):
A method for treating a cancer in a subject, comprising administering to the subject an effective amount of the pharmaceutical composition of  claim 13 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.68519
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15037104', '15018710', '14518294', '14734957', '14517682']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6668892556084111
- 35 USC 102 Novelty (BERT): 0.5348157548216225
- Combined Prediction Score: 0.6536819055297323
- Mean Citation Score: 345.902172
- Max Citation Score: 358.13632
- Similarity Product: 223.62634498168944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test